Viewing Study NCT01920932

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-05-07 @ 9:49 AM
Study NCT ID: NCT01920932
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-03
First Post: 2013-08-06
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma
Sponsor: St. Jude Children's Research Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage II Childhood Hodgkin Lymphoma View
None Stage III Childhood Hodgkin Lymphoma View
None Stage IV Childhood Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pediatric cancer View
None Hodgkin lymphoma View
None Targeted therapy View
None Frontline therapy View
None Brentuximab vedotin View
None Quality of Life View
None OEPA/COPDac View